Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $3.71 Million - $4.8 Million
92,500 New
92,500 $3.71 Million
Q1 2024

May 09, 2024

BUY
$42.03 - $53.55 $411,894 - $524,790
9,800 New
9,800 $424,000
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $204,048 - $306,144
-4,800 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$45.3 - $60.27 $217,440 - $289,296
4,800 New
4,800 $271,000
Q3 2020

Nov 13, 2020

SELL
$47.45 - $62.95 $441,285 - $585,435
-9,300 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$41.6 - $63.4 $1.06 Million - $1.62 Million
-25,500 Reduced 73.28%
9,300 $440,000
Q2 2019

Aug 12, 2019

SELL
$62.09 - $86.14 $7.79 Million - $10.8 Million
-125,400 Reduced 78.28%
34,800 $2.24 Million
Q1 2019

May 10, 2019

SELL
$52.92 - $81.17 $2.25 Million - $3.46 Million
-42,600 Reduced 21.01%
160,200 $13 Million
Q4 2018

Feb 13, 2019

BUY
$43.37 - $59.54 $6.69 Million - $9.19 Million
154,300 Added 318.14%
202,800 $11 Million
Q3 2018

Nov 09, 2018

SELL
$42.88 - $53.7 $1.06 Million - $1.33 Million
-24,700 Reduced 33.74%
48,500 $2.5 Million
Q2 2018

Aug 08, 2018

BUY
$40.53 - $50.7 $2.94 Million - $3.68 Million
72,500 Added 10357.14%
73,200 $3.05 Million
Q1 2018

May 09, 2018

SELL
$44.08 - $55.05 $431,984 - $539,490
-9,800 Reduced 93.33%
700 $31,000
Q4 2017

Feb 09, 2018

BUY
$50.3 - $64.39 $191,140 - $244,682
3,800 Added 56.72%
10,500 $528,000
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $305,252 - $399,119
6,700
6,700 $340,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.